NFKB1 and type 2 diabetes mellitus: Like AA, LXA4 prevented the development of alloxan- and streptozotocin-induced type 1 and type 2 diabetes mellitus, respectively, and suppressed IL-6 and TNF-α production and NF-kB expression.